Search Within

Michel W J Sadelain

Formats
  1. Meeting Abstract (289)
  2. Journal Article (279)
  3. Review (5)
  4. Editorial (4)
  5. Conference Paper (3)
  6. Research Letter (3)
  7. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (585)
  2. Department of Medicine (585)
  3. GSK Faculty (585)
  4. Hematologic Malignancies Research (585)
  5. Hematologic Malignancies, Division of (585)
  6. Molecular Pharmacology and Chemistry Program Faculty (585)

More Groups

People
  1. Isabelle Riviere (200)
  2. Renier Brentjens (116)
  3. Xiuyan Wang (91)
  4. Jae Park (83)
  5. Jorge Mansilla-Soto (43)
  6. Kevin Curran (36)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (21)
  4. 2022 (18)
  5. 2021 (23)
  6. 2020 (16)

More Years

Publications
  1. Blood (133)
  2. Molecular Therapy (56)
  3. Cancer Research (24)
  4. Journal of Clinical Oncology (18)
  5. Nature Biotechnology (13)
  6. Blood Cells, Molecules, and Diseases (12)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. Nature Publishing Group (126)
  3. Elsevier Inc. (49)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (19)
  6. Cell Press (16)

More Publishers

Results (585)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LiPS-A3S, a human genomic site for robust expression of inserted transgenes
    Journal Article

    Kotini, A. G.; Sadelain, M.; Papapetrou, E. P.
    Molecular Therapy - Nucleic Acids (2016)

    Fulltext@MSK | Save
  • Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy
    Meeting Abstract

    Geyer, M.; Park, J.; Rivière, I.; Senechal, B.; Hsu, M.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Radiation sensitizes tumor cells to CAR T cell immunotherapy
    Meeting Abstract

    DeSelm, C. J.; Hamieh, M.; Sadelain, M.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity
    Journal Article

    Maus, M. V.; Plotkin, J.; Jakka, G.; Stewart-Jones, G.; Rivière, I.; Merghoub, T.; Wolchok, J.; Renner, C.; Sadelain, M.
    Molecular Therapy - Oncolytics (2016)

    Fulltext@MSK | Save
  • Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
    Journal Article

    Paszkiewicz, P. J.; Fräßle, S. P.; Srivastava, S.; Sommermeyer, D.; Hudecek, M.; Drexler, I.; Sadelain, M.; Liu, L.; Jensen, M. C.; Riddell, S. R.; more...
    Journal of Clinical Investigation (2016)

    Fulltext@MSK | Save
  • Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy
    Journal Article

    Perna, F.; Sadelain, M.
    Translational Cancer Research (2016)

    Fulltext@MSK | Save
  • Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8(+) T cells for adoptive immunotherapy of cancer and infections
    Journal Article

    Hasan, A. N.; Selvakumar, A.; Shabrova, E.; Liu, X. R.; Afridi, F.; Heller, G.; Riviere, I.; Sadelain, M.; Dupont, B.; O'Reilly, R. J.
    Clinical and Experimental Immunology (2016)

    Fulltext@MSK | Save
  • Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
    Journal Article

    Cherkassky, L.; Morello, A.; Villena-Vargas, J.; Feng, Y.; Dimitrov, D. S.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Clinical Investigation (2016)

    Fulltext@MSK | Save
  • Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis
    Meeting Abstract

    Raffin, C.; Zhou, Y.; Piccoli, L.; Lanzavecchia, A.; Sadelain, M.; Bluestone, J. A.
    Journal of Immunology (2016)

    Fulltext@MSK | Save
  • Impact of disease burden on long-term outcome of CD19-targeted CAR modified T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Sadelain, M.; Brentjens, R.
    Haematologica (2016)

    Fulltext@MSK | Save